Anthony M. Manning

CIK 1716468 · Chief Scientific Officer · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$673.2K

Companies

3

Total Filings

52

Lifetime Open-Market Net

-$6.52M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
GLUE	Director	10,000	$18.23	$182.3K	-$180.1K	4	2026-05-22
PTN	Director	36,080	$13.61	$490.9K	$0	9	2024-07-16
MOMENTA PHARMACEUTICALS INC (MNTA) Delisted	Chief Scientific Officer	0	—	—	-$6.34M	39	2020-10-01

Recent Filings · Page 6 of 6

52 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2017-12-13	PTN	Grant (A)	+15,000	$0	EDGAR
2017-09-11	PTN	Grant (A)	+54,000	$0	EDGAR

Showing 51–52 of 52

Prev Page 6 of 6

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.